ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Mortality"

  • Abstract Number: 1284 • ACR Convergence 2023

    Baseline Data’s Role in Predicting All-cause Mortality in Chinese Rheumatoid Arthritis Patients: Findings from the China Registry of Rheumatoid Arthritis (CREDIT) Study

    Kangping Huang1, Mucong Li1, Chen Yu1, Nan Jiang1, Jiuliang zhao1, Qian Wang1, Peng Yin2, Xinping Tian1, Mengtao Li1 and Xiaofeng Zeng1, 1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 2Chinese Center for Disease Control and Prevention, Beijing, China

    Background/Purpose: Rheumatoid arthritis (RA) poses significant challenges for patients in China due to prolonged disease duration prior to a definitive diagnosis, resulting in comorbidities and…
  • Abstract Number: 1704 • ACR Convergence 2023

    Esophageal Mucosal Erosions Can Predict the Deterioration of Lung Function over a Four-year Follow-up Period and Long-term Mortality in Patients with Interstitial Lung Disease Associated with Scleroderma

    gerlando Natalello1, enrico De Lorenzis1, Ludovica Berardini2, lucrezia verardi1, pier giacomo Cerasuolo1, Alfredo Papa3, Italo De Vitis3, Francesco Varone2, Luca Richeldi2, Maria Antonietta D'Agostino1 and Silvia Bosello1, 1Division of Rheumatology - Catholic University of the Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy, 2Division of Pulmonology - Catholic University of the Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy, 3Division of Gastroenterology - Catholic University of the Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy

    Background/Purpose: Interstitial lung disease (ILD) is a major cause of morbidity and disease-related death in systemic sclerosis (SSc). Esophageal disease is common in SSc, and…
  • Abstract Number: 2277 • ACR Convergence 2023

    Patients with Systemic Lupus Erythematosus: A Comparative Study Between Two Large, Multi-centric, Spanish and Argentinian Registers, Focused on Outcomes Differences

    Iñigo Rúa-Figueroa1, Rosana M Quintana2, JULIA MARTINEZ BARRIO3, Mercedes García4, Maria Galindo-Izquierdo5, Lucila Garcia6, Jaime Calvo- Alén7, Carla Gobbi8, Esther Uriarte Isacelaya9, Paula Alba8, Eva Tomero Muriel10, Verónica Bellomio11, Mercedes Freire González12, Susana Roverano6, Victor Martinez-Taboada13, Analia Patricia Alvarez14, Eva Salgado-Pérez15, Cesar Enrique Graf16, Paloma Vela17, Cecilia Pisoni14, Antonio Fernandez-Nebro18, Valeria Arturi19, Clara Sanguesa Gomez20, Catalina Gomez14, Javier Narvaez21, Zulema Plaza22, Gregorio Santos Soler23, Silvia Papasidero24, José Ángel Hernández Beriain25, Raul Paniego6, Angela Pecondón26, Maria Celina De La Vega6, Oihane Ibarguengoitia-Barrena27, Emma Civit8, Gema Bonilla28, Luciana Gonzalez Lucero14, Vicente Torrente-Segarra29, Maria Victoria Martire6, Ana Paula Cacheda30, Rodrigo Aguila Maldonado14, Maria J. García-Villanueva31, Sergio Gordon14, Clara Moriano Morales32, Marina Micelli6, Loreto Horcada33, Romina Nieto34, Nuria Lozano Rivas35, Gretel Rausch14, Guillermo Pons-Estel34 and Jose-Maria Pego-Reigosa36, 1Rheumatology, Hospital de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain, 2Centro Regional de Enfermedades Autoinmunes y Reumticas (CREAR), Grupo Oroño, Rosario, Argentina, 3Rheumatology, Gregorio Marañon University Hospital, Madrid, Spain, 4Hospital Interzonal General de Agudos José de San Martín, La Plata, Argentina, 5Rheumatology, University Hospital of 12 de Octubre, Madrid, Spain, 6RELESSAR, CABA, Argentina, 7Rheumatology, Bioaraba Research Unit, Hospital Universitario Araba, Vitoria, Spain, 8RELESSAR, Cordoba, Argentina, 9Rheumatology, University Hospital of Donosti, San Sebastián, Spain, 10Rheumatology, Hospital La Princesa, Madrid, Spain, 11RELESSAR, Tucuman, Argentina, 12Rheumatology department, Complexo Hospitalario Universitario A Coruña (CHUAC). Instituto de Investigación Biomédica A Coruña (INIBIC), A Coruña, Spain, 13Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain, 14Study Group of the Argentine Society of Rheumatology for Systemic Lupus Erythematosus, Buenos Aires, Argentina, 15Department of Rheumatology, University Hospital of Ourense, Ourense, Spain, 16RELESSAR, ENTRE RIOS, Argentina, 17Department of Rheumatology, University Hospital of Alicante, Alicante, Spain, 18Hospital Regional Universitario de Málaga, Malaga, Spain, 19RELESSAR, La Plata, Argentina, 20Severo Ochoa Hospital, Madrid, Spain, 21Hospital Universitario de Bellvitge, Barcelona, Spain, 22Universidad Autónoma de Madrid, Madrid, Spain, 23Rheumatology, Hospital Marina Baixa Villajoyosa, Alicante, Spain, 24Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 25Rheumatology, Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain, 26Hospital Universitario Miguel Servet, Zaragoza, Madrid, Spain, 27Galdakao-Usansolo University Hospital, Bilbao, Spain, 28Department of Rheumatology, Hospital Clínico Universitario La Paz, Madrid, Spain, 29Department of Rheumatology, Hospital de Sant Joan Despí Moises Broggi,, Sant Joan Despí, Spain, 30Department of Rheumatology, Hospital Son Llatzer, Palma de Mallorca, Spain, 31Hospital Ramón y Cajal, Madrid, Spain, 32Rheumatology, Hospital Universitario de León, León, Spain, 33Hospital de Navarra, Pamplona, Spain, 34RELESSAR, Rosario, Argentina, 35Department of Rheumatology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain, 36Rheumatology, Hospital do Meixoeiro, Vigo, Spain

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multi-organ involvement, associated with substantial morbidity and mortality. A characteristic that distinguishes lupus patients…
  • Abstract Number: 0124 • ACR Convergence 2023

    Utility of the 2019 EULAR/ACR SLE Classification Criteria Score as Predictor for Mortality and Hospitalizations in a Population-Based Cohort: The Lupus Midwest Network

    Gabriel Figueroa-Parra1, Andrew Hanson2, Alain Sanchez-Rodriguez3, Jose Meade-Aguilar1, Cynthia Crowson3 and Ali Duarte-Garcia3, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 3Mayo Clinic, Rochester, MN

    Background/Purpose: Patients with SLE experience increased all-cause mortality and have a higher risk of hospitalization than the general population. Recently the classification criteria for SLE…
  • Abstract Number: 0660 • ACR Convergence 2023

    Cigarette Smoking Increases the Risk of All-Cause Mortality in Male Patients with Systemic Sclerosis: An Analysis of the EUSTAR Cohort

    Jacopo Ciaffi1, Sophie Liem2, Saad Ahmed2, Eva Hoekstra2, Piotr Wiland3, Tatsuya Atsuma4, Gabriella Szucs5, Alexandra Balbir-Gurman6, Laszlo Czirjak7, Elisabetta Zanatta8, Ina Koetter9, Joerg Henes10, marco Matucci Cerinic11, Paolo Airò12, Francesco Ursini13, Thomas Huizinga2 and Jeska de Vries-Bouwstra2, 1IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, 2Leiden University Medical Center, Leiden, Netherlands, 3Wroclaw University of Medicine, Wroclaw, Poland, 4Hokkaido University, Department of Rheumatology, Endocrinology and Nephrology, Sapporo, Japan, 5University of Debrecen, Department of Rheumatology, Debrecen, Hungary, 6Rheumatology Institute, Rambam Health Care Campus and Rappaport Faculty of |Medicine, Technion, Haifa, Israel, 7Dept. Rheumatol Immunol, Medical School, university of Pecs, Pecs, Hungary, 8Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Padova, Padua, Italy, 9University Hospital Eppendorf, Prisdorf, Germany, 10University Hospital Tuebingen, Tuebingen, Germany, 11Unit of Immunology, Rheumatology, Allergy and Rare diseases, IRCCS San Raffaele Hospital, Milan, Milan, Italy, 12Spedali Civili di Brescia, Scleroderma UNIT, UOC Reumatologia ed Immunologia Clinica, Piazzale Spedali Civili 1, 25123, Brescia, Italy, 13IRCCS Istituto Ortopedico Rizzoli, Bologna, Netherlands

    Background/Purpose: Cigarette smoking is an established risk factor for mortality in the general population but, in systemic sclerosis (SSc), evidence about the role of smoking…
  • Abstract Number: 1288 • ACR Convergence 2023

    Frailty Is Associated with Higher Risk of Readmission in Patients with Rheumatoid Arthritis

    Waqas Tahir1, Yenny Rosli2, Christopher Leung3, K Wysham4, Jiha Lee5, Radjiv Goulabchand6, Una Makris7, Siddharth Singh8 and Namrata Singh9, 1Mayo Clinic, Jacksonville, FL, 2University of Washington, Seattle, WA, 3Georgetown University School of Medicine, Washington, DC, 4VA Puget Sound/University of Washington, Seattle, WA, 5University of Michigan, Ann Arbor, MI, 6University of California San Diego, La Jolla, CA, 7UT Southwestern Medical Center and Dallas VA, Dallas, TX, 8University of California San Diego, San Diego, CA, 9University of Washington, Bellevue, WA

    Background/Purpose: With the advent of new therapies and increasing life expectancy, there is a rising number of older adults living with rheumatoid arthritis (RA). Patients…
  • Abstract Number: 1798 • ACR Convergence 2023

    Association Between Knee Osteoarthritis and Mortality: A Serial Propensity Score-matched Cohort Study

    Sunggun Lee1, Minkyoung Oh2, Mi-Yeong Kim3, Minyoung Her1 and Seong-Ho Kim1, 1Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea, 2Department of pharmacology, Inje University College of Medicine, Busan, South Korea, 3Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea

    Background/Purpose: The association between symptomatic knee osteoarthritis (OA) and higher cardiovascular disease (CVD) mortality is well established; however, findings from previous studies that utilized regression…
  • Abstract Number: 2319 • ACR Convergence 2023

    Changes in the Causes and Predictors of Lupus Mortality in Spain Through the Last Decades: Data from the RELESSER Registry

    Clara Moriano Morales1, Jaime Calvo- Alén2, Iñigo Rúa-Figueroa3, MARIA ELVIRA DIEZ ALVAREZ1, Cristina Bermúdez4, JULIA MARTINEZ BARRIO5, Maria Galindo-Izquierdo6, Alejandro Olivé-Marqués7, Eva Tomero Muriel8, Antonio Fernandez-Nebro9, Mercedes Freire González10, Olaia Fernandez-Berrizbeitia11, Ana Pérez Gómez12, Esther Uriarte Isacelaya13, carlos Marras Fernández-Cid14, Carlos Montilla-Morales15, Gregorio Santos Soler16, Ricardo Blanco17, Manuel Rodríguez-Gómez18, PALOMA VELA19, Alina Boteanu20, Javier Narvaez21, Victor Martinez-Taboada22, Blanca Hernández-Cruz23, Jose Luis Andreu-Sánchez24, José Ángel Hernández Beriain25, Lorena Expósito26, Raúl Menor-Almagro27, Mónica Ibáñez-Barceló28, Ivan Castellvi29, Carles Galisteo30, Enrique Raya31, Víctor Quevedo-Vila32, Tomás Vazquez-Rodriguez33, jesús Ibáñez34 and Jose-Maria Pego-Reigosa35, 1Rheumatology, Hospital Universitario de León, León, Spain, 2Rheumatology, Bioaraba Research Unit, Hospital Universitario Araba, Vitoria, Spain, 3Rheumatology, Hospital de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain, 4Bioaraba Research Unit, Vitoria, Spain, 5Rheumatology, Gregorio Marañon University Hospital, Madrid, Spain, 6Rheumatology, University Hospital of 12 de Octubre, Madrid, Spain, 7Rheumatology, Private Practice, Barcelona, Spain, 8Rheumatology, Hospital La Princesa, Madrid, Spain, 9Hospital Regional Universitario de Málaga, Malaga, Spain, 10Rheumatology department, Complexo Hospitalario Universitario A Coruña (CHUAC). Instituto de Investigación Biomédica A Coruña (INIBIC), A Coruña, Spain, 11Spanish Health Care Service, Bilbao, Spain, 12Rheumatology, Hospital Principe de Asturias, Alcalá de Henares, Spain, 13Rheumatology, University Hospital of Donosti, San Sebastián, Spain, 14Rheumatology, Hospital Virgen Arrixaca, Murcia, Spain, 15Rheumatology, University Hospital of Salamanca, Salamanca, Spain, 16Rheumatology, Hospital Marina Baixa Villajoyosa, Alicante, Spain, 17Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 18Rheumatology, Hospital Ourense, Ourense, Spain, 19Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, 20Hospital Universitario Ramón y Cajal, Departamento de Reumatología, Madrid, Spain, 21Hospital Universitario de Bellvitge, Barcelona, Spain, 22Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain, 23Rheumatology, Hospital Virgen de la Macarena, Sevilla, Spain, 24Rheumatology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain, 25Rheumatology, Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain, 26Rheumatology, Hospital de Canarias, Tenerife, Spain, 27Rheumatology, Hospital Jerez, Puerto De Santa María, Spain, 28Rheumatology, Hospital Universitari Son Llàtzer, Palma de Mallorca, Spain, 29Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau, Sant Just Desvern, Spain, 30Hospital Universitario Parc Taulí, Sabadell, Spain, 31Rheumatology, Hospital San Cecilio, Granada, Spain, 32Rheumatology, Hospital Monforte de Lemos, Lugo, Spain, 33Rheumatology, Complejo Hospitalario Universitario de Ferrol, A Coruña, Spain, 34Rheumatology, Hospital Ribera Povisa, Vigo, Spain, 35Rheumatology, Hospital do Meixoeiro, Vigo, Spain

    Background/Purpose: The mortality in Systemic Lupus Erythematosus (SLE) varies largely across different countries most probably due to social, healthcare and ethnic differences. We need to…
  • Abstract Number: 0125 • ACR Convergence 2023

    Decreasing Ischemic Heart Disease, but Increasing Cancer Among the Underlying Causes of Death in Decedents with Lupus Nephritis

    snehin Rajkumar1 and Ram Singh2, 1University of California Los Angeles, Irvine, CA, 2UCLA David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: Patients with lupus nephritis may die of active systemic lupus erythematosus (SLE) disease, end-stage renal disease (ESRD) and its complications as well as of…
  • Abstract Number: 0709 • ACR Convergence 2023

    Survival of Adults with IgA Vasculitis

    Alojzija Hocevar1, JAKA OSTROVRŠNIK2, vESNA JURČIĆ3, Matija Tomšič4 and Ziga Rotar5, 1Department of Rheumatology, Universitiy Medical Centre Ljubljana, Ljubljana, Slovenia, 2UKC Ljubljana, Ljubljana, Slovenia, 3University of Ljubljana, Medical Faculty, Institute of Pathology, Ljubljana, Slovenia, 4Department of Rheumatology, University Medical Centre LJubljana, Ljubljana, Slovenia, 5University Medical Centre Ljubljana, Ljubljana, Slovenia

    Background/Purpose: Data on survival of adults with IgA vasculitis (IgAV) are scarce. The aim of our study was to estimate for the first time the…
  • Abstract Number: 1374 • ACR Convergence 2023

    Interstitial Lung Disease Is Frequent in Primary Sjögren’s Syndrome and Is Associated with Reduced Survival

    Marco Sprecher1, Florine Weber2, Kastriot Kastrati3, Helmut Prosch4, Natasha Moe5, Emily Langballe6, Cosimo Bruni7, Oyvind Molberg8, Phuong Phuong Diep9, Christian Clarenbach10, Paul Studenic11, Helena Andersson8, Oyvind Midtvedt12, Torhild Garen8, Karoline Lerang13, Thomas Frauenfelder14, Helga Radner15, Oliver Distler7 and Anna Maria Hoffmann-Vold16, 1Dept of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 2Dept of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 3Dept of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna (Austria), Vienna, Austria, 4Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria, 5Dept of Radiology, University Hospital Oslo, Oslo, Norway, 6Universitetet i Oslo, Oslo, Norway, 7Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 8Dept of Rheumatology, University Hospital Oslo, Oslo, Norway, 9Dept of Respiratory diseases, University Hospital Oslo, Oslo, Norway, 10Dept of Pulmonology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 11Medical University of Vienna and Karolinska Institutet (sweden), Vienna, Austria, 12Oslo University Hospital, Oslo, Norway, 13Department of Rheumatology, Oslo University Hospital, Oslo, Norway, 14Dept of Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 15Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 16Oslo University Hospital, Department of Rheumatology, Oslo, Norway

    Background/Purpose: Interstitial lung disease (ILD) has been reported to be present in 10-15% of patients with primary Sjögren's syndrome (pSS). Knowledge on risk factors predicting…
  • Abstract Number: 1816 • ACR Convergence 2023

    Hyperuricemia – Especially “Metabolic Hyperuricemia” – Is Independently Associated with Higher Risk of Fatty Liver

    Janis Timsans1, Jenni Kauppi1, Hannu Kautiainen2 and Markku Kauppi3, 1Päijät-Häme Central Hospital, Lahti, Finland, 2University of Helsinki, Folkhälsan Research Center, Helsinki, Finland, 3University of Helsinki, Helsinki, Finland

    Background/Purpose: Elevated serum uric acid (SUA) level is rather prevalent in the general population, and it is associated with numerous comorbidities and mortality. Etiology of…
  • Abstract Number: 2406 • ACR Convergence 2023

    Risk of Large Vessel Complications in Patients with Giant Cell Arteritis, a Population-based Study

    Mohanad Elfishawi1, Mahmut Kaymakci1, Sara Achenbach2, Cynthia Crowson1, Tanaz Kermani3, Cornelia M. Weyand4, Matthew Koster1 and Kenneth Warrington1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, MN, Rochester, MN, 3University of California Los Angeles, Los Angeles, CA, 4Mayo Clinic School of Medicine and Stanford University, Rochester, MN

    Background/Purpose: Large vessel (LV) complications are known to occur in patients with giant cell arteritis (GCA). The magnitude of risk compared to the general population…
  • Abstract Number: 0127 • ACR Convergence 2023

    Time Trends, Cumulative Incidence, and Impact on Survival of Interstitial Lung Disease in Systemic Sclerosis: Results from a Population-based Cohort Study

    Anukul Karn1, Sara Achenbach2, Alicia Hinze3, Cynthia Crowson1 and Ashima Makol2, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, MN, Rochester, MN, 3Mayo Clinic - Rochester, MN, Rochester, MN

    Background/Purpose: Cardiopulmonary complications are the number one cause of mortality in Systemic sclerosis (SSc). We studied the prevalence, cumulative incidence, predictors and impact of interstitial…
  • Abstract Number: 0762 • ACR Convergence 2023

    Liver Disease Is a Common Feature of HA20 That Causes Significant Morbidity Associated with Interferon Induction

    Magdalena Harasimowicz1, Deborah Stone2, Manuel Carpio Tumba1, Tina Romeo2, Urekha Karri1, Patrycja Hoffmann3, Helen Leavis4, Alexander Miethke5, Theo Heller2, Anjali Rai2, Ivona Aksentijevich2, amanda ombrello6, Daniel Kastner7 and Daniella Schwartz1, 1University of Pittsburgh, Pittsburgh, PA, 2NIH, Bethesda, MD, 3NIH, Vienna, VA, 4Infection Immunity Utrecht, Utrecht, Netherlands, 5Cincinnati Children's Hospital, Cincinnati, OH, 6National Institutes of Health, Rockville, MD, 7National Human Genome Research Institute, Bethesda, MD

    Background/Purpose: Heterozygous loss-of-function TNFAIP3 mutations cause A20 haploinsufficiency (HA20), an early-onset immune dysregulatory disease1. While HA20 was initially described as an inherited form of Behcet’s…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology